Sanofi Consumer Healthcare Intrinsic Value
Sanofi Consumer Healthcare (SANOFICONR) median intrinsic value is ₹1429.17 from 8 valuation models (range ₹953–₹2382), vs current price ₹4763.90 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit SANOFICONR stock live price.
SANOFICONR Valuation Methods Summary — DCF, Graham Number & P/E
Sanofi Consumer Healthcare intrinsic value across 8 models vs current price ₹4763.90 — upside/downside and value range per method. Also explore SANOFICONR share price charts to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1728.98 | ₹1383.18 - ₹2074.78 | -63.7% | EPS: ₹78.59, Sector P/E: 22x |
| Book Value Method | asset | ₹952.78 | ₹857.50 - ₹1048.06 | -80.0% | Book Value/Share: ₹118.70, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1429.17 | ₹1286.25 - ₹1572.09 | -70.0% | Revenue/Share: ₹320.87, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1905.56 | ₹1715.00 - ₹2096.12 | -60.0% | EBITDA: ₹284.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹1429.17 | ₹1286.25 - ₹1572.09 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1429.17 | ₹1286.25 - ₹1572.09 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹2381.95 | ₹2143.76 - ₹2620.14 | -50.0% | ROE: 66.3%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1429.17 | ₹1286.25 - ₹1572.09 | -70.0% | EPS: ₹78.59, BVPS: ₹118.70 |
SANOFICONR Intrinsic Value vs Market Price — All Valuation Models
Sanofi Consumer Healthcare fair value range ₹953–₹2382 vs current market price ₹4763.90 across 8 valuation models. Read SANOFICONR dividend payout details for the complete payout history and dividend yield track record.
SANOFICONR Intrinsic Value Analysis — Undervalued or Overvalued?
Sanofi Consumer Healthcare median intrinsic value ₹1429.17, current price ₹4763.90 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of SANOFICONR?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sanofi Consumer Healthcare (SANOFICONR) is ₹1429.17 (median value). With the current market price of ₹4763.90, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹952.78 to ₹2381.95, indicating ₹952.78 - ₹2381.95.
Is SANOFICONR undervalued or overvalued?
Based on our multi-method analysis, Sanofi Consumer Healthcare (SANOFICONR) appears to be trading above calculated value by approximately 70.0%.
SANOFICONR Financial Health — Key Ratios vs Industry Benchmarks
Sanofi Consumer Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 66.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 37.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.71x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SANOFICONR Cash Flow Quality — Operating & Free Cash Flow
Sanofi Consumer Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹439 Cr | ₹439 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |